TrialPanorama/TrialPanorama-database huggingface dataset:
Study: 7946588

Group type: EXPERIMENTAL
Intervention: Low-dose gamma-interferon (gamma IFN) at doses of 100, 200, or 400 micrograms, administered daily or weekly for a minimum of 3 months after a 2-week cycle.
Number of subjects: 36

Group type: COMPARATOR
Intervention: Comparison to other low-dose gamma IFN trials.
Number of subjects: 36
Study: 3680556

Group type: EXPERIMENTAL
Intervention: Nimesulide 100 mg oral doses
Number of subjects: 23

Group type: EXPERIMENTAL
Intervention: Nimesulide 200 mg/d PO
Number of subjects: 23

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 23
Study: 29132646

Group type: EXPERIMENTAL
Intervention: Stable teams
Number of subjects: 46

Group type: COMPARATOR
Intervention: Dynamic teams
Number of subjects: 46
Study: 26469360

Group type: EXPERIMENTAL
Intervention: Active NMES + swallow exercise
Number of subjects: 170

Group type: COMPARATOR
Intervention: Sham NMES + swallow exercise
Number of subjects: 170
Study: 24650164

Group type: EXPERIMENTAL
Intervention: Prime Time intervention
Number of subjects: 253
Study: 20961633

Group type: EXPERIMENTAL
Intervention: Immediate PCI (IMM)
Number of subjects: 598

Group type: EXPERIMENTAL
Intervention: Rescue PCI (RES)
Number of subjects: 598

Group type: EXPERIMENTAL
Intervention: Standard Treatment Arm (STA)
Number of subjects: 598
Study: 20565333

Group type: EXPERIMENTAL
Intervention: Memantine at 20 mg/day
Number of subjects: 63

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 63

Group type: EXPERIMENTAL
Intervention: Memantine
Number of subjects: 63

Group type: EXPERIMENTAL
Intervention: Neurophysiological measurements
Number of subjects: 63
Study: 17689932

Group type: EXPERIMENTAL
Intervention: Adalimumab (TNFalpha inhibitor)
Number of subjects: 6
Study: 16355744

Group type: EXPERIMENTAL
Intervention: Walking towards the targets (depth-presentation condition)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Walking in a direction incompatible with the locations of the targets (width-presentation condition)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Blindly walking in a direction other than toward the targets (depth-presentation condition)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Blindly walking in a direction other than toward the targets (width-presentation condition)
Number of subjects: 0
Study: 12062893

Group type: EXPERIMENTAL
Intervention: 20 mg paroxetine
Number of subjects: 6

Group type: EXPERIMENTAL
Intervention: 60 mg paroxetine
Number of subjects: 6

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 6
Study: 8848890

Group type: EXPERIMENTAL
Intervention: Neostigmine 50 micrograms kg‐1 with atropine 20 micrograms kg‐1
Number of subjects: 80

Group type: EXPERIMENTAL
Intervention: Edrophonium 1 mg kg‐1 with atropine 10 micrograms kg‐1
Number of subjects: 80
Study: 1982774

Group type: EXPERIMENTAL
Intervention: 25 mg propiomazine
Number of subjects: 12
Study: 100808

Group type: EXPERIMENTAL
Intervention: Methamphetamine (10 mg)
Number of subjects: 24

Group type: EXPERIMENTAL
Intervention: Diphenhydramine (100 mg)
Number of subjects: 24

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 24
Study: 31129129

Group type: EXPERIMENTAL
Intervention: Secukinumab
Number of subjects: 0
Study: 28837025

Group type: EXPERIMENTAL
Intervention: Triptorelin 0.3mg (Group A)
Number of subjects: 40

Group type: COMPARATOR
Intervention: Triptorelin 0.4mg (Group B)
Number of subjects: 40
Study: 27266362

Group type: EXPERIMENTAL
Intervention: Yttrium-90 (90Y) radioembolization alone
Number of subjects: 23

Group type: EXPERIMENTAL
Intervention: Yttrium-90 (90Y) radioembolization with sorafenib
Number of subjects: 23

Group type: COMPARATOR
Intervention: Control group (Yttrium-90 alone)
Number of subjects: 23
Study: 23474109

Group type: EXPERIMENTAL
Intervention: High Ki67 staining index (Ki67-SI) ≥Q3
Number of subjects: 468

Group type: COMPARATOR
Intervention: RT alone
Number of subjects: 468

Group type: COMPARATOR
Intervention: RT with ADT
Number of subjects: 468

Group type: EXPERIMENTAL
Intervention: Ki67-SI
Number of subjects: 468
Study: 21113612

Group type: EXPERIMENTAL
Intervention: 24-hour protocol at 60% of VO(2max)
Number of subjects: 27

Group type: EXPERIMENTAL
Intervention: Adventure Race over 6 days at self-selected race pace (38% of VO(2max))
Number of subjects: 27

Group type: EXPERIMENTAL
Intervention: Both protocols
Number of subjects: 27
Study: 19049993

Group type: EXPERIMENTAL
Intervention: Immediate administration of misoprostol after mifepristone (600 microg vaginally)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: 36-38 h administration of misoprostol after mifepristone (600 microg vaginally)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: 36-38 h administration of misoprostol
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Immediate administration of misoprostol
Number of subjects: 0
Study: 17182162

Group type: EXPERIMENTAL
Intervention: Low cognitive support
Number of subjects: 81

Group type: COMPARATOR
Intervention: High cognitive support
Number of subjects: 81

Group type: EXPERIMENTAL
Intervention: Executive functions measure (perseverative errors on the Wisconsin Card Sorting Test)
Number of subjects: 81

Group type: EXPERIMENTAL
Intervention: Fluid intelligence measure (Cattell's culture fair test)
Number of subjects: 81
Study: 14656755

Group type: EXPERIMENTAL
Intervention: Inactivated influenza vaccine
Number of subjects: 696

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 696
Study: 11231032

Group type: EXPERIMENTAL
Intervention: Branched chain amino acids
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: L-threonine with pyridoxal 5-phosphate
Number of subjects: 0

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 0
Study: 9855514

Group type: EXPERIMENTAL
Intervention: 50 mg of sildenafil
Number of subjects: 27

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 27
Study: 7727908

Group type: EXPERIMENTAL
Intervention: Opiate sedation plus low dose midazolam (1 mg/hour)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Opiate sedation
Number of subjects: 0
Study: 2536052

Group type: EXPERIMENTAL
Intervention: Preventive home visits every third month over 3 years
Number of subjects: 285

Group type: COMPARATOR
Intervention: Control group (no preventive home visits)
Number of subjects: 285

Group type: EXPERIMENTAL
Intervention: Preventive home visits
Number of subjects: 285

Group type: COMPARATOR
Intervention: Control group
Number of subjects: 285
Study: 5556052

Group type: EXPERIMENTAL
Intervention: Streptokinase
Number of subjects: 23

Group type: COMPARATOR
Intervention: Heparin
Number of subjects: 23
Study: 30985449

Group type: EXPERIMENTAL
Intervention: Restrictive IV fluid resuscitation strategy (≤ 60 mL/kg of IV fluid)
Number of subjects: 109

Group type: COMPARATOR
Intervention: Usual care
Number of subjects: 109
Study: 28453978

Group type: EXPERIMENTAL
Intervention: Intra-nasal administration of Oxytocin
Number of subjects: 90

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 90
Study: 25761587

Group type: EXPERIMENTAL
Intervention: dienogest + estradiol valerate (E2V) for 9 months
Number of subjects: 78

Group type: COMPARATOR
Intervention: gonadotrophin‐releasing hormone analogue (GnRH‐a) monthly for 6 months
Number of subjects: 78

Group type: EXPERIMENTAL
Intervention: dienogest + estradiol valerate (E2V)
Number of subjects: 78

Group type: COMPARATOR
Intervention: gonadotrophin‐releasing hormone analogue (GnRH‐a)
Number of subjects: 78
Study: 23825408

Group type: EXPERIMENTAL
Intervention: Cognitive reappraisal task with positive emotions
Number of subjects: 0
Study: 21667768

Group type: EXPERIMENTAL
Intervention: Magical film (experimental group)
Number of subjects: 56

Group type: COMPARATOR
Intervention: Nonmagical film (control group)
Number of subjects: 56
Study: 19500383

Group type: EXPERIMENTAL
Intervention: Complex intervention including caregiver support groups and counselling
Number of subjects: 390

Group type: COMPARATOR
Intervention: Usual care (control group)
Number of subjects: 390
Study: 16763820

Group type: EXPERIMENTAL
Intervention: 68Ga-DOTATOC
Number of subjects: 15

Group type: COMPARATOR
Intervention: [18F]FDG
Number of subjects: 15

Group type: COMPARATOR
Intervention: Comparison of 68Ga-DOTATOC and [18F]FDG
Number of subjects: 15
Study: 15327620

Group type: EXPERIMENTAL
Intervention: Misoprostol 600 microg (200 microg orally and 400 microg sublingually)
Number of subjects: 160

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 160
Study: 11315575

Group type: EXPERIMENTAL
Intervention: P-wave signal-averaging using MAC 5000 device
Number of subjects: 123

Group type: EXPERIMENTAL
Intervention: P-wave signal-averaging
Number of subjects: 123
Study: 9243239

Group type: EXPERIMENTAL
Intervention: Early amniocentesis (EA)
Number of subjects: 804

Group type: EXPERIMENTAL
Intervention: Chorion villus sampling (CVS)
Number of subjects: 804

Group type: COMPARATOR
Intervention: Control (no invasive procedures)
Number of subjects: 804
Study: 8044013

Group type: EXPERIMENTAL
Intervention: Chinese medicine group (CMG) treated with Tongjingbao and Angelicae Complex Injection
Number of subjects: 50

Group type: COMPARATOR
Intervention: Western medicine group (WMG) treated with Gentamycin, Dexamethasone, Chymotrypsin
Number of subjects: 50
Study: 3255916

Group type: EXPERIMENTAL
Intervention: Formulation A of tripotassium dicitrato bismuthate (TDB)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Formulation B of tripotassium dicitrato bismuthate (TDB)
Number of subjects: 0
Study: 28633477

Group type: EXPERIMENTAL
Intervention: Loop diuretics (high doses)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Diuretics withdrawal
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Diuretics (general use)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Diuretics decrease (from a small randomized study)
Number of subjects: 0
Study: 28849302

Group type: COMPARATOR
Intervention: Education Group (EG)
Number of subjects: 138

Group type: COMPARATOR
Intervention: Intervention Group (IG)
Number of subjects: 138

Group type: COMPARATOR
Intervention: Education and Intervention Group (E + IG)
Number of subjects: 138

Group type: COMPARATOR
Intervention: Control Group (CG)
Number of subjects: 138
Study: 26096106

Group type: EXPERIMENTAL
Intervention: Complete denture (CD) prosthesis
Number of subjects: 40
Study: 23439417

Group type: EXPERIMENTAL
Intervention: Vibram FiveFinger running shoes for 10 wk (experimental group)
Number of subjects: 36

Group type: COMPARATOR
Intervention: Traditional running shoes for 10 wk (control group)
Number of subjects: 36
Study: 21401865

Group type: EXPERIMENTAL
Intervention: rPSGL-Ig (1 mg/kg systemic dose with pretransplant allograft ex vivo treatment)
Number of subjects: 47

Group type: EXPERIMENTAL
Intervention: rPSGL-Ig
Number of subjects: 47

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 47
Study: 18362297

Group type: EXPERIMENTAL
Intervention: Weight loss group
Number of subjects: 75

Group type: COMPARATOR
Intervention: Control group
Number of subjects: 75
Study: 16520053

Group type: EXPERIMENTAL
Intervention: Miniaturized CPB
Number of subjects: 40

Group type: COMPARATOR
Intervention: Standard CPB
Number of subjects: 40
Study: 12948258

Group type: EXPERIMENTAL
Intervention: Standard ACTH (250 microg) test
Number of subjects: 16

Group type: EXPERIMENTAL
Intervention: Low dose ACTH (1 microg) test
Number of subjects: 16

Group type: COMPARATOR
Intervention: Both low dose and standard dose ACTH tests
Number of subjects: 16
Study: 10890484

Group type: EXPERIMENTAL
Intervention: Histamine2-receptor antagonists or antacids
Number of subjects: 141887

Group type: COMPARATOR
Intervention: No SU prophylaxis
Number of subjects: 141887
Study: 10170453

Group type: EXPERIMENTAL
Intervention: Venlafaxine
Number of subjects: 2953

Group type: COMPARATOR
Intervention: SSRIs (fluoxetine, fluvoxamine, sertraline, paroxetine)
Number of subjects: 2953

Group type: COMPARATOR
Intervention: TCAs (amitriptyline, imipramine, desipramine, nortriptyline)
Number of subjects: 2953
Study: 8213274

Group type: EXPERIMENTAL
Intervention: Surgical treatment
Number of subjects: 929
Study: 2947462

Group type: EXPERIMENTAL
Intervention: Ipratropium bromide metered-dose inhaler (40 micrograms four times a day)
Number of subjects: 164

Group type: COMPARATOR
Intervention: Metaproterenol metered-dose inhaler (1,500 micrograms four times a day)
Number of subjects: 164

Group type: EXPERIMENTAL
Intervention: Ipratropium bromide
Number of subjects: 164
Study: 30462260

Group type: EXPERIMENTAL
Intervention: Rifamycin SV‐MMX® 400 mg twice daily
Number of subjects: 835

Group type: COMPARATOR
Intervention: Ciprofloxacin 500 mg twice daily
Number of subjects: 835
Study: 27467767

Group type: EXPERIMENTAL
Intervention: 1×4-min high-intensity interval training (1HIIT), 1×4 min bout at 85-95% HRpeak, three times/week
Number of subjects: 50

Group type: COMPARATOR
Intervention: Moderate-intensity continuous training (MICT), 30 min at 60-70% HRpeak, five times/week
Number of subjects: 50

Group type: COMPARATOR
Intervention: 4×4-min high-intensity interval training (4HIIT), 4×4 min bouts at 85-95% HRpeak, three times/week
Number of subjects: 50
Study: 24395069

Group type: EXPERIMENTAL
Intervention: Fibrin glue (FG) group (n = 48)
Number of subjects: 95

Group type: COMPARATOR
Intervention: Control group (n = 47)
Number of subjects: 95
Study: 24094794

Group type: EXPERIMENTAL
Intervention: PEP-Imagery
Number of subjects: 114

Group type: EXPERIMENTAL
Intervention: PEP-Semantic
Number of subjects: 114

Group type: COMPARATOR
Intervention: Control
Number of subjects: 114
Study: 21094019

Group type: EXPERIMENTAL
Intervention: Integrated interpersonal cognitive‐behavioral group treatment (ICBT)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Wait list condition (WL)
Number of subjects: 0
Study: 18283282

Group type: EXPERIMENTAL
Intervention: High-intensity progressive resistance training (PRT)
Number of subjects: 78
Study: 16645969

Group type: EXPERIMENTAL
Intervention: Budesonide 9 mg/day
Number of subjects: 139

Group type: EXPERIMENTAL
Intervention: Prednisolone 7.5 mg/day
Number of subjects: 139

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 139
Study: 12553635

Group type: EXPERIMENTAL
Intervention: Pure lanolin cream used twice daily for 4 weeks
Number of subjects: 92

Group type: COMPARATOR
Intervention: Ammonium lactate 12% cream used twice daily for 4 weeks
Number of subjects: 92
Study: 11023726

Group type: EXPERIMENTAL
Intervention: Urethral catheterization before vaginal cleansing
Number of subjects: 167

Group type: COMPARATOR
Intervention: Urethral catheterization after vaginal cleansing
Number of subjects: 167
Study: 8840633

Group type: EXPERIMENTAL
Intervention: Colloidal bismuth subcitrate (CBS) 240 mg twice daily (Group 1)
Number of subjects: 63

Group type: COMPARATOR
Intervention: Placebo I (Group 2)
Number of subjects: 63

Group type: EXPERIMENTAL
Intervention: Sucralfate 2.0 g twice daily (Group 3)
Number of subjects: 63

Group type: COMPARATOR
Intervention: Placebo II (Group 4)
Number of subjects: 63
Study: 1458144

Group type: COMPARATOR
Intervention: Nifedipine (60 mg/day); 14% required additional diuretics.
Number of subjects: 102

Group type: EXPERIMENTAL
Intervention: Enalapril (40 mg/day); 76% required diuretics.
Number of subjects: 102
Study: 6829919

Group type: EXPERIMENTAL
Intervention: 2-chloroprocaine
Number of subjects: 60

Group type: COMPARATOR
Intervention: Lidocaine
Number of subjects: 60
Study: 31370811

Group type: EXPERIMENTAL
Intervention: Neurofeedback Training Group (NF group)
Number of subjects: 179

Group type: COMPARATOR
Intervention: Methylphenidate group (MPH group)
Number of subjects: 179
Study: 29982727

Group type: EXPERIMENTAL
Intervention: GEN-003 30 µg antigen/25 µg adjuvant
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: GEN-003 30 µg antigen/50 µg adjuvant
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: GEN-003 30 µg antigen/75 µg adjuvant
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: GEN-003 60 µg antigen/25 µg adjuvant
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: GEN-003 60 µg antigen/50 µg adjuvant
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: GEN-003 60 µg antigen/75 µg adjuvant
Number of subjects: 0

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: GEN-003
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: GEN-003 60 µg antigen plus 50 or 75 µg adjuvant
Number of subjects: 0
Study: 26803595

Group type: EXPERIMENTAL
Intervention: DHA supplementation (1000 mg DHA; 200 mg EPA)
Number of subjects: 94

Group type: EXPERIMENTAL
Intervention: EPA supplementation (1000 mg EPA; 200 mg DHA)
Number of subjects: 94

Group type: COMPARATOR
Intervention: Placebo (sunola oil)
Number of subjects: 94
Study: 23989707

Group type: COMPARATOR
Intervention: Conventional instrumentation (group A)
Number of subjects: 45

Group type: EXPERIMENTAL
Intervention: Patient-specific instrumentation (group B)
Number of subjects: 45
Study: 25276669

Group type: EXPERIMENTAL
Intervention: Chart presenting pregnancy risk with combined pills
Number of subjects: 630

Group type: EXPERIMENTAL
Intervention: Chart presenting pregnancy risk with intrauterine devices
Number of subjects: 630

Group type: EXPERIMENTAL
Intervention: Chart presenting pregnancy risk with condoms
Number of subjects: 630
Study: 20155788

Group type: EXPERIMENTAL
Intervention: Hémoionic
Number of subjects: 85

Group type: COMPARATOR
Intervention: Control
Number of subjects: 85
Study: 17629087

Group type: EXPERIMENTAL
Intervention: CA 72-4
Number of subjects: 47
Study: 16258100

Group type: EXPERIMENTAL
Intervention: Functional Assessment of Cancer Treatment-Fatigue scores
Number of subjects: 104

Group type: EXPERIMENTAL
Intervention: Functional Assessment of Cancer Treatment-Endocrine Symptoms scores
Number of subjects: 104

Group type: EXPERIMENTAL
Intervention: Incidence of moderate-severe cognitive dysfunction by High Sensitivity Cognitive Screen
Number of subjects: 104

Group type: COMPARATOR
Intervention: Quality of life differences between patients and controls
Number of subjects: 104
Study: 12114419

Group type: EXPERIMENTAL
Intervention: ISIS 3521 (2 mg/kg/day as continuous i.v. infusion for 21 of 28 days)
Number of subjects: 37

Group type: EXPERIMENTAL
Intervention: ISIS 5132 (2 mg/kg/day as continuous i.v. infusion for 21 of 28 days)
Number of subjects: 37
Study: 10198937

Group type: EXPERIMENTAL
Intervention: Music programme guide for parents of blind children
Number of subjects: 0
Study: 8673001

Group type: EXPERIMENTAL
Intervention: Beta-carotene supplementation (30 mg/day) for up to 2 years
Number of subjects: 0

Group type: COMPARATOR
Intervention: Control group (without beta-carotene supplementation)
Number of subjects: 0
Study: 2181856

Group type: EXPERIMENTAL
Intervention: Glucose polymer Polycose (100 or 150 g daily for 6 months)
Number of subjects: 21

Group type: COMPARATOR
Intervention: Control (no energy supplementation)
Number of subjects: 21
Study: 7194063

Group type: EXPERIMENTAL
Intervention: etofylline clofibrate (Duolip) treatment
Number of subjects: 221
Study: 31539578

Group type: EXPERIMENTAL
Intervention: Garner task for PS
Number of subjects: 70

Group type: EXPERIMENTAL
Intervention: Garner task for ED
Number of subjects: 70

Group type: EXPERIMENTAL
Intervention: Reaction time analysis
Number of subjects: 70
Study: 30241990

Group type: EXPERIMENTAL
Intervention: Omega-3 (EPA 740 mg and DHA 400 mg daily)
Number of subjects: 50

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 50
Study: 26886460

Group type: EXPERIMENTAL
Intervention: Brace treatment (thoracolumbosacral orthosis, at least 18 h/d)
Number of subjects: 167
Study: 25862546

Group type: EXPERIMENTAL
Intervention: Acetaminophen
Number of subjects: 0

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 0
Study: 22822191

Group type: EXPERIMENTAL
Intervention: Forced air warming
Number of subjects: 1

Group type: EXPERIMENTAL
Intervention: Conductive fabric warming
Number of subjects: 1

Group type: COMPARATOR
Intervention: Control conditions
Number of subjects: 1
Study: 21419288

Group type: EXPERIMENTAL
Intervention: 4% articaine with 1:100,000 epinephrine
Number of subjects: 86

Group type: EXPERIMENTAL
Intervention: 4% articaine with 1:200,000 epinephrine
Number of subjects: 86
Study: 19526752

Group type: EXPERIMENTAL
Intervention: Chinese herbal medicine (Xinyue Capsule and compound Tanshinon Tablet)
Number of subjects: 80

Group type: COMPARATOR
Intervention: Control group (conventional Western medicine alone)
Number of subjects: 80
Study: 18190583

Group type: EXPERIMENTAL
Intervention: Cranberry capsules (108 mg)
Number of subjects: 8

Group type: EXPERIMENTAL
Intervention: Cranberry capsules (36 mg)
Number of subjects: 8

Group type: EXPERIMENTAL
Intervention: Cranberry capsules (not specified dosage)
Number of subjects: 8

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 8
Study: 15668544

Group type: EXPERIMENTAL
Intervention: efavirenz (EFV) 600 mg once daily
Number of subjects: 202

Group type: EXPERIMENTAL
Intervention: nevirapine (NVP) 200 mg twice daily
Number of subjects: 202

Group type: EXPERIMENTAL
Intervention: nevirapine (NVP) 400 mg once daily
Number of subjects: 202

Group type: EXPERIMENTAL
Intervention: nevirapine (NVP) 400 mg once daily + efavirenz (EFV) 800 mg once daily
Number of subjects: 202

Group type: COMPARATOR
Intervention: NVP 200 mg twice daily
Number of subjects: 202

Group type: COMPARATOR
Intervention: EFV 600 mg once daily
Number of subjects: 202

Group type: COMPARATOR
Intervention: NVP 400 mg once daily
Number of subjects: 202

Group type: COMPARATOR
Intervention: NVP 400 mg once daily + EFV 800 mg once daily
Number of subjects: 202
Study: 11854670

Group type: EXPERIMENTAL
Intervention: Monopoly coating
Number of subjects: 10

Group type: EXPERIMENTAL
Intervention: Permaseal coating
Number of subjects: 10

Group type: COMPARATOR
Intervention: Control (uncoated)
Number of subjects: 10
Study: 10199943

Group type: EXPERIMENTAL
Intervention: Gamma-scintigraphy with light tablet (12 mm, different isotope)
Number of subjects: 7

Group type: EXPERIMENTAL
Intervention: Gamma-scintigraphy with dense tablet (12 mm, different isotope)
Number of subjects: 7

Group type: EXPERIMENTAL
Intervention: Non-parametric statistics (Wilcoxon test)
Number of subjects: 7

Group type: COMPARATOR
Intervention: Commonly applied method (parametric procedures)
Number of subjects: 7
Study: 7796241

Group type: EXPERIMENTAL
Intervention: 5% lignocaine ointment
Number of subjects: 45

Group type: EXPERIMENTAL
Intervention: 30% lignocaine ointment
Number of subjects: 45

Group type: COMPARATOR
Intervention: Control site (no treatment)
Number of subjects: 45
Study: 2196496

Group type: EXPERIMENTAL
Intervention: Routine screening ultrasound
Number of subjects: 915

Group type: COMPARATOR
Intervention: Usual prenatal care
Number of subjects: 915
Study: 19514

Group type: COMPARATOR
Intervention: Carbuterol 2 mg
Number of subjects: 8

Group type: EXPERIMENTAL
Intervention: Carbuterol 4 mg
Number of subjects: 8

Group type: EXPERIMENTAL
Intervention: Metaproterenol 20 mg
Number of subjects: 8

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 8
Study: 31031095

Group type: EXPERIMENTAL
Intervention: 432 Hz tuned music
Number of subjects: 33

Group type: COMPARATOR
Intervention: 440 Hz tuned music
Number of subjects: 33